home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  July 16, 2024
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 456 active entries

MediGene AG

Lochhamer Str. 11
Martinsried, 82152, Bavaria

Phone: +49-89-89 56 32-0
Fax: +49-89-89 56 32-20

Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


A biopharmaceutical product company, MediGene AG is focussed
on the discovery, development and commercialisation of high
value molecular therapeutics. With strong backing from
Europe's leading finance houses and venture capitalists,
MediGene's experienced management and skilled research teams
have brought together a unique combination of recombinant
tumour vaccines and novel targets and therapeutics for
cardiac diseases. The company's proprietary technologies are
aimed at the treatment of prevalent cancers such as cervical
and ovarian cancer and malignant melanoma, as well as the
treatment of congestive heart failure. Starting in 1995, MediGene has more than 50 employees and has raised over DM 70 million.

Last update of this entry: before October 1999.

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.